Valo Health receives USD 110 Million Series B from Koch
Valo Health launched in September with USD 100 million and a couple of acquisitions under its belt to transform drug development and cut years off R&D timelines. Now, it is filling with USD 110 million from Koch Disruptive Technologies that will bolster the development of its technology and the discovery and development of its drug programs.
In January, the company raised USD 190 million in the first close of its series B round from The Public Sector Pension Investment Board (PSP Investments), Flagship Pioneering, Invus Public Equities, HBM Healthcare Investments, Atinum Investment, and Mirae Asset Capi...
